Colon cancer blood test offers new screening option
A blood test for colon cancer performed well in a study published Wednesday, offering a new kind of screening for a leading cause of cancer deaths.
The test looks for DNA fragments shed by tumor cells and precancerous growths. It’s already for sale in the U.S. for $895, but has not been approved by the Food and Drug Administration and most insurers do not cover it. The maker of the test, Guardant Health, anticipates an FDA decision this year.
In the study, the test caught 83% of the cancers but very few of the precancerous growths found by colonoscopy, the gold standard for colon cancer screening. Besides spotting tumors, colonoscopies can prevent the disease by removing precancerous growths called polyps.
But some people avoid the exam because of the hassle of getting time off work or the day-ahead preparation that involves drinking a strong laxative to empty the bowels.
Related articles
Four people killed in a house explosion in southwestern Missouri
GOODHOPE, Mo. (AP) — Four people in rural Missouri died when an explosion that could be heard 10 mil2024-05-21Int'l Bicycles, Baby Strollers and Toys Fair Held in Hebei
Contact Us HomeNewsHighlightACWF NewsSocietyWom2024-05-21China's HIV Infections, Mortality Rates at Low Level Globally
Contact Us HomeNewsHighlightACWF NewsSocietyWom2024-05-21Improved Logistics Spur Global Market in 'Double 11' Shopping Festival
Contact Us HomeNewsHighlightACWF NewsSocietyWom2024-05-21Biden says Brown v. Board of Education ruling was about more than education
WASHINGTON (AP) — The landmark 1954 Supreme Court ruling that desegregated schools was about more th2024-05-21World Children's Day Celebrated with Light Shows Across China
Contact Us HomeNewsHighlightACWF NewsSocietyWom2024-05-21
atest comment